|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/14/23 Herbalife Nutrition Ltd. 10-K 12/31/22 109:24M Donnelley … Solutions/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 5.77M
2: EX-10 Ex-10.33 HTML 87K
3: EX-21 Ex-21.1 HTML 190K
4: EX-23 Ex-23.1 HTML 30K
5: EX-31 Ex-31.1 HTML 35K
6: EX-31 Ex-31.2 HTML 35K
7: EX-32 Ex-32.1 HTML 33K
8: EX-32 Ex-32.2 HTML 33K
14: R1 Cover Page HTML 103K
15: R2 Consolidated Balance Sheets HTML 133K
16: R3 Consolidated Balance Sheets (Parenthetical) HTML 39K
17: R4 Consolidated Statements of Income HTML 106K
18: R5 Consolidated Statements of Comprehensive Income HTML 57K
19: R6 Consolidated Statements of Comprehensive Income HTML 36K
(Parenthetical)
20: R7 Consolidated Statements of Changes in HTML 79K
Shareholders' Deficit
21: R8 Consolidated Statements of Changes in HTML 43K
Shareholders' Deficit (Parenthetical)
22: R9 Consolidated Statements of Cash Flows HTML 132K
23: R10 Organization HTML 36K
24: R11 Basis of Presentation HTML 240K
25: R12 Inventories HTML 56K
26: R13 Leases HTML 269K
27: R14 Long-Term Debt HTML 292K
28: R15 Employee Compensation Plans HTML 46K
29: R16 Contingencies HTML 78K
30: R17 Shareholders' Deficit HTML 166K
31: R18 Share-Based Compensation HTML 181K
32: R19 Segment Information HTML 267K
33: R20 Derivative Instruments and Hedging Activities HTML 793K
34: R21 Income Taxes HTML 380K
35: R22 Fair Value Measurements HTML 200K
36: R23 Transformation Program HTML 130K
37: R24 Detail of Certain Balance Sheet Accounts HTML 78K
38: R25 Basis of Presentation (Policies) HTML 315K
39: R26 Basis of Presentation (Tables) HTML 130K
40: R27 Inventories (Tables) HTML 57K
41: R28 Leases (Tables) HTML 272K
42: R29 Long-Term Debt (Tables) HTML 125K
43: R30 Shareholders' Deficit (Tables) HTML 123K
44: R31 Share-Based Compensation (Tables) HTML 144K
45: R32 Segment Information (Tables) HTML 258K
46: R33 Derivative Instruments and Hedging Activities HTML 774K
(Tables)
47: R34 Income Taxes (Tables) HTML 351K
48: R35 Transformation Program (Tables) HTML 128K
49: R36 Fair Value Measurements (Tables) HTML 198K
50: R37 Detail of Certain Balance Sheet Accounts (Tables) HTML 70K
51: R38 Organization - Additional Information (Detail) HTML 33K
52: R39 Basis of Presentation - Additional Information HTML 128K
(Detail)
53: R40 Basis of Presentation - Net Property, Plant and HTML 47K
Equipment (Detail)
54: R41 Basis of Presentation - Summary of Reconciliation HTML 46K
of Cash, Cash Equivalents and Restricted Cash for
Balance Sheets and Cash Flows (Detail)
55: R42 Basis of Presentation - Computation of Basic and HTML 42K
Diluted Earnings Per Share (Detail)
56: R43 Inventories - Classes of Inventory (Detail) HTML 41K
57: R44 Leases - Additional Information (Detail) HTML 32K
58: R45 Leases - Summary of Lease Assets and Liabilities HTML 63K
Recognized Within Consolidated Balance Sheets
(Detail)
59: R46 Leases - Summary of Lease Assets and Liabilities HTML 33K
Recognized Within Consolidated Balance Sheets
(Parenthetical) (Detail)
60: R47 Leases - Summary of Lease Cost Recognized Over the HTML 52K
Lease Term (Detail)
61: R48 Leases - Summary of Lease Cost Recognized Over the HTML 51K
Lease Term (Parenthetical) (Detail)
62: R49 Leases - Summary of Annual Scheduled Lease HTML 69K
Payments (Detail)
63: R50 Leases - Summary of Annual Scheduled Lease HTML 32K
Payments (Parenthetical) (Detail)
64: R51 Leases - Summary of Weighted-average Remaining HTML 43K
Lease Term and Weighted-average Discount Rate
(Detail)
65: R52 Leases - Summary of Supplemental Cash Flow HTML 45K
Information Related to Leases (Detail)
66: R53 Long-Term Debt - Schedule of Long-Term Debt HTML 61K
(Detail)
67: R54 Long-Term Debt - Schedule of Long-Term Debt HTML 50K
(Parenthetical) (Detail)
68: R55 Long-Term Debt - Additional Information (Detail) HTML 527K
69: R56 Long-Term Debt - Schedule of Redemption Prices HTML 50K
expressed as Percentages of Principal Amount
(Detail)
70: R57 Long-Term Debt - Annual Scheduled Principal HTML 51K
Payments of Debt (Detail)
71: R58 Employee Compensation Plans - Additional HTML 43K
Information (Detail)
72: R59 Contingencies - Additional Information (Detail) HTML 111K
73: R60 Shareholders' Deficit - Additional Information HTML 105K
(Detail)
74: R61 Shareholders' Deficit - Summary of Changes in HTML 59K
Accumulated Other Comprehensive Loss (Detail)
75: R62 Share-Based Compensation - Additional Information HTML 115K
(Detail)
76: R63 Share-Based Compensation - Summary of Weighted HTML 41K
Average Assumptions Used in Calculation of Fair
Value for Service Condition Awards Granted
(Detail)
77: R64 Share-Based Compensation - Summary of Activities HTML 111K
Under Share-Based Compensation Plans (Detail)
78: R65 Share-Based Compensation - Summary of Activities HTML 56K
Under Share-Based Compensation Plans
(Parenthetical) (Detail)
79: R66 Segment Information - Additional Information HTML 43K
(Detail)
80: R67 Segment Information - Reconciliation of Revenue HTML 41K
from Segments to Consolidated (Detail)
81: R68 Segment Information - Reconciliation of Operating HTML 71K
Profit (Loss) from Segments to Consolidated
(Detail)
82: R69 Segment Information - Reconciliation of Operating HTML 36K
Profit (Loss) from Segments to Consolidated
(Parenthetical) (Detail)
83: R70 Segment Information - Schedule of Entity-Wide HTML 48K
Information, Revenue from External Customers by
Products and Services (Detail)
84: R71 Segment Information - Schedule of Revenue from HTML 48K
External Customers Attributed to Foreign Countries
by Geographic Area (Detail)
85: R72 Segment Information - Schedule of Property, Plant HTML 42K
and Equipment and Deferred Tax Assets by
Geographic Area (Detail)
86: R73 Derivative Instruments and Hedging Activities - HTML 79K
Additional Information (Detail)
87: R74 Derivative Instruments and Hedging Activities - HTML 175K
Summary of Foreign Currency Forward Contracts
Outstanding (Detail)
88: R75 Derivative Instruments and Hedging Activities - HTML 40K
Gains (Losses) Relating to Derivative Instruments
Recorded in Other Comprehensive (Loss) Income
(Detail)
89: R76 Derivative Instruments and Hedging Activities - HTML 56K
Effect of Cash Flow Hedging Relationships on
Consolidated Statements of Income (Detail)
90: R77 Derivative Instruments and Hedging Activities - HTML 37K
Gains (Losses) Relating to Derivative Instruments
Not Designated As Hedging Instruments Recorded to
Income (Detail)
91: R78 Income Taxes - Components of Income before Income HTML 41K
Taxes (Detail)
92: R79 Income Taxes - Components of Income Tax Expense HTML 60K
(Detail)
93: R80 Income Taxes - Deferred Tax Assets and Liabilities HTML 72K
(Detail)
94: R81 Income Taxes - Additional Information (Detail) HTML 94K
95: R82 Income Taxes - Reconciliation between Provision HTML 56K
for Income Taxes at Statutory Rate and Provision
for Income Taxes at Effective Tax Rate (Detail)
96: R83 Income Taxes - Changes Occurred in Amount of HTML 51K
Unrecognized Tax Benefits (Detail)
97: R84 Fair Value Measurements - Derivative Assets and HTML 63K
Liabilities Measured at Fair Value (Detail)
98: R85 Fair Value Measurements - Offsetting of Derivative HTML 46K
Assets (Detail)
99: R86 Fair Value Measurements - Offsetting of Derivative HTML 46K
Liabilities (Detail)
100: R87 Transformation Program - Additional Information HTML 36K
(Detail)
101: R88 Transformation Program - Schedule of Costs Related HTML 39K
to the Transformation (Details)
102: R89 Transformation Program - Schedule of Changes in HTML 47K
the Liabilities Related to the Transformation
Program (Details)
103: R90 Detail of Certain Balance Sheet Accounts - HTML 41K
Additional Information (Detail)
104: R91 Detail of Certain Balance Sheet Accounts - HTML 48K
Schedule of Other Current Liabilities (Detail)
107: XML IDEA XML File -- Filing Summary XML 205K
105: XML XBRL Instance -- hlf-20221231_htm XML 7.14M
106: EXCEL IDEA Workbook of Financial Reports XLSX 275K
11: EX-101.CAL XBRL Calculations -- hlf-20221231_cal XML 267K
10: EX-101.DEF XBRL Definitions -- hlf-20221231_def XML 1.15M
9: EX-101.LAB XBRL Labels -- hlf-20221231_lab XML 2.40M
12: EX-101.PRE XBRL Presentations -- hlf-20221231_pre XML 1.73M
13: EX-101.SCH XBRL Schema -- hlf-20221231 XSD 355K
108: JSON XBRL Instance as JSON Data -- MetaLinks 658± 1.08M
109: ZIP XBRL Zipped Folder -- 0000950170-23-002787-xbrl Zip 777K
| EX-32 |
Exhibit 32.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
Pursuant to 18 U.S.C. Section 1350
Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Annual Report of Herbalife Nutrition Ltd., or the Company, on Form 10-K for the period ended December 31, 2022 as filed with the Securities and Exchange Commission on the date hereof, or the Report, I, Alexander Amezquita, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: (1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and (2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Chief Financial Officer |
Dated: February 14, 2023
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 2/14/23 | 8-K | ||
| For Period end: | 12/31/22 | 5 | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/14/24 Herbalife Ltd. 10-K 12/31/23 106:19M Donnelley … Solutions/FA 11/01/23 Herbalife Ltd. S-8 11/01/23 5:125K Donnelley … Solutions/FA 11/01/23 Herbalife Ltd. 10-Q 9/30/23 87:15M Donnelley … Solutions/FA 8/02/23 Herbalife Ltd. 10-Q 6/30/23 87:21M Donnelley … Solutions/FA 5/02/23 Herbalife Ltd. S-8 5/02/23 4:102K Donnelley … Solutions/FA 5/02/23 Herbalife Ltd. 10-Q 3/31/23 95:18M Donnelley … Solutions/FA |